Manuela Semeraro

Dr. Manuela Semeraro

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Manuela SemeraroManuela Semeraro
Manuela Semeraro
GBGhalia Boubaker
Ghalia Boubaker
MSMirco Scaccaglia
Mirco Scaccaglia
JMJoachim Müller
Joachim Müller
AVAnitha Vigneswaran
Anitha Vigneswaran
Andrew HemphillAndrew Hemphill
Andrew Hemphill
Thiosemicarbazones and their metal complexes have been studied for their biological activities against bacteria, cancer cells and protozoa. Short-term in vitro treatment with one gold (III) complex (C3) and its salicyl-thiosemicarbazone ligand (C4) selectively inhibited proliferation of T. gondii. Transmission Electron Microscopy (TEM) detected transient structural alterations in the parasitophorous vacuole membrane and the tachyzoite cytoplasm, but the mitochondrial membrane potential appeared unaffected by these compounds. Proteins potentially interacting with C3 and C4 were identified using differential affinity chromatography coupled with mass spectrometry (DAC-MS). Moreover, long-term in vitro treatment was performed to investigate parasitostatic or parasiticidal activity of the compounds. DAC-MS identified 50 ribosomal proteins binding both compounds, and continuous drug treatments for up to 6 days caused the loss of efficacy. Parasite tolerance to both compounds was, however, rapidly lost in their absence and regained shortly after re-exposure. Proteome analyses of six T. gondii ME49 clones adapted to C3 and C4 compared to the non-adapted wildtype revealed overexpression of ribosomal proteins, of two transmembrane proteins involved in exocytosis and of an alpha/beta hydrolase fold domain-containing protein. Results suggest that C3 and C4 may interfere with protein biosynthesis and that adaptation may be associated with the upregulated expression of tachyzoite transmembrane proteins and transporters, suggesting that the in vitro drug tolerance in T. gondii might be due to reversible, non-drug specific stress-responses mediated by phenotypic plasticity.

1 March 2024 in Vector-Borne and Zoonotic Diseases
Verified
Journal Article
Closed access
MGMarco Genchi
Marco Genchi
IEIván Rodríguez Escolar
Iván Rodríguez Escolar
Rodrigo MorchónRodrigo Morchón
Rodrigo Morchón
Manuela SemeraroManuela Semeraro
Manuela Semeraro
LKLaura Helen Kramer
Laura Helen Kramer
AVAlice Vismarra
Alice Vismarra
Background:Dirofilaria immitis, the agent of canine and feline heartworm disease (HWD), is a widespread mosquito-borne helminth. The true prevalence of HW infection in cats is likely underestimated due to the difficulty in establishing a definitive diagnosis. Aedes albopictus, a recognized competent vector for D. immitis, is currently considered the most invasive mosquito species worldwide and Italy presents the highest abundance of Ae. albopictus in Europe. Materials and Methods: The present study was aimed at evaluating the current seroprevalence of D. immitis antibodies in cats in Italy. Further, the ecological niche model (ENM) was applied to evaluate the potential future risk of feline HWD associated with the presence of Ae. albopictus. Results: Sera of 812 Italian cats were analyzed, and the average prevalence of D. immitis antibodies was 12%. Seropositivity was significantly associated with age (<6 years), whereas there was no association with sex or geographical area. Data obtained with the risk map showed that the highest risk of infection was found in northern inland areas and along coastal areas, whereas the lowest risk was identified at higher altitudes. The ENM correctly classified most of the areas where D. immitis seropositive cats were found, with 80.4% occurring in high and very high-risk areas. Conclusions: Results of the present study suggest that cats in Italy are exposed to D. immitis infection, and that routine prevention should be part of the general health care protocols in cats. Moreover, the resulting risk maps indicate that areas with a suitable habitat for Ae. albopictus may put cats at risk of exposure to D. immitis.

10 February 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
ADAbdeldjalil DAHMANE
Abdeldjalil DAHMANE
AVAlice Vismarra
Alice Vismarra
KPKarine Passebosc-Faure
Karine Passebosc-Faure
NRNassiba Reghaissia
Nassiba Reghaissia
DBDjamel BAROUDI
Djamel BAROUDI
LALaatamna AbdElkarim
Laatamna AbdElkarim
Toxoplasmosis is one of the most important foodborne diseases in humans, potentially acquired by ingesting unpasteurized goat milk. This study examined the role of goat milk as a source of infection of Toxoplasma gondii for humans in Algeria. Sera, blood, and milk samples collected from 106 female goats were tested for the presence of antibodies against T. gondii and its DNA, using indirect ELISA and PCR, respectively. Multiplex PCR was performed using 15 microsatellite markers to determine the clonal type of the T. gondii DNA detected. Seropositive results were found in 51 she-goats (48.11%). T. gondii DNA was detected in 16 (15.09%) and 15 (14.15%) blood and milk samples, respectively. In total, 15 (29.41%) out of 51-seropositive goats were PCR-positive for blood, while only 6 of them (6/15, 40%) showed the presence of T. gondii DNA in their milk. A fair correlation was found between indirect ELISA and PCR assays for T. gondii detection in milk (K = 0.2243) and blood (K = 0.28300), with a substantial difference in the screening ability of the tests (G2 = 38.96, p < 0.0001). The genotyping of samples could not be completed, but showed the absence of type I and type III lineages in goats from the Mila region, northeastern Algeria. The Algerian goat population is highly exposed to T. gondii, with a potentially increased risk of parasite transmission to humans via milk consumption.

5 June 2025 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
AVAlice Vismarra
Alice Vismarra
MGMarco Genchi
Marco Genchi
AMAlessia Maltoni
Alessia Maltoni
Manuela SemeraroManuela Semeraro
Manuela Semeraro
LKLaura Helen Kramer
Laura Helen Kramer
MFMarta Fozzer
Marta Fozzer
Background: Dirofilaria immitis, the agent of canine and feline heartworm disease, and Dirofilaria repens, the agent of subcutaneous dirofilariosis, are widespread mosquito-borne helminths. The present study is aimed at updating current knowledge of the composition of potential vector species in the northern region of Emilia-Romagna, a traditionally endemic area for D. immitis and D. repens. Methods: Mosquitoes were collected in 2022 and 2023 as part of the regional surveillance plan for West Nile Virus (WNV). The capture zones included peri-urban and rural areas and mosquitoes were captured with CDC-CO2 traps. DNA from approximately 30% of female mosquitoes of each captured species (Culex pipiens, Aedes caspius, Aedes vexans, Aedes albopictus) was extracted and analyzed for the presence of D. immitis and D. repens. Results: A total of 140 pools (~ 20 mosquitoes each) in 2022 and 133 in 2023 have been analyzed. DNA of D. immitis was identified in 14 pools in 2022 and in 15 pools in 2023. None of the pools was positive for D. repens. In 2022, about 85% of the positive pools belonged to Ae. caspius species (11/13) and the other three pools to Ae. vexans. In 2023, 73% of the positive pools belonged to Ae. caspius, followed by Ae. vexans and Ae. albopictus (both 13.3%). A significant overlap emerged from the same traps positioned in Ferrara and Bologna provinces, which tested positive for D. immitis in both 2022 and 2023. Conclusions: These data highlight how, despite the abundance of Cx. pipiens captured, the most receptive species for D. immitis appear to be Ae. caspius and Ae. vexans. Furthermore, the geographical data highlights how the areas of the province of Ferrara and Bologna are the main geographical reservoirs of the parasite. Graphical

1 August 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Manuela SemeraroManuela Semeraro
Manuela Semeraro
GBGhalia Boubaker
Ghalia Boubaker
MSMirco Scaccaglia
Mirco Scaccaglia
DIDennis Imhof
Dennis Imhof
MSMaria Cristina Ferreira de Sousa
Maria Cristina Ferreira de Sousa
Andrew HemphillAndrew Hemphill
Andrew Hemphill
Background: Toxoplasma gondii is a globally widespread parasite responsible for toxoplasmosis, a zoonotic disease with significant impact on both human and animal health. The current lack of safe and effective treatments underscores the need for new drugs. Earlier, thiosemicarbazones (TSCs) and their metal complexes have shown promising activities against T. gondii. This study evaluated a gold (III) complex C3 and its TSC ligand C4 for safety in host immune cells and zebrafish embryos, followed by efficacy assessment in a murine model for chronic toxoplasmosis. Methods: The effects on viability and proliferation of murine splenocytes were determined using Alamar Blue assay and BrdU ELISA, and potential effects of the drugs on zebrafish (Danio rerio) embryos were detected through daily light microscopical inspection within the first 96 h of embryo development. The parasite burden in treated versus non-treated mice was measured by quantitative real-time PCR in the brain, eyes and the heart. Results: Neither compound showed immunosuppressive effects on the host immune cells but displayed dose-dependent toxicity on early zebrafish embryo development, suggesting that these compounds should not be applied in pregnant animals. In the murine model of chronic toxoplasmosis, C4 treatment significantly reduced the parasite load in the heart but not in the brain or eyes, while C3 did not have any impact on the parasite load. Conclusions: These results highlight the potential of C4 for further exploration but also the limitations of current approaches in effectively reducing parasite burden in vivo.

20 August 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ABArianna Bucella
Arianna Bucella
Manuela SemeraroManuela Semeraro
Manuela Semeraro
Laura GiovatiLaura Giovati
Laura Giovati
LALorenza Artesani
Lorenza Artesani
Ruggero BettiniRuggero Bettini
Ruggero Bettini
AVAlice Vismarra
Alice Vismarra
Background/Objectives: Toxoplasmosis, a zoonotic disease caused by Toxoplasma gondii, typically is asymptomatic in immunocompetent individuals but causes severe complications in immunocompromised subjects and during pregnancy. Current treatments such as pyrimethamine and sulfadiazine are effective for acute infections but cannot eliminate encysted bradyzoites and have significant side effects. The antimicrobial killer peptide (KP) has interesting therapeutic potential, but its intracellular delivery is challenging; hyaluronate-based nanoparticles loaded with KP (KP-NPs) were evaluated to target T. gondii-infected cells that overexpress CD44. Methods: KP-NPs made of chitosan and hyaluronate were produced by microfluidics and were characterized for size, surface charge, encapsulation efficiency, and stability under stress conditions. After excluding their toxicity, their activity was tested in vitro against Candida albicans and T. gondii as free tachyzoite or in infected human foreskin fibroblasts (HFFs). Results: KP was efficiently encapsulated in nanoparticles and protected from harsh acidic conditions at high temperature. Preliminary in vitro testing against C. albicans showed that, at the lowest candidacidal concentration of KP (2.5 μg/mL), KP-NPs killed 90.97% of yeast cells. KP itself proved to be non-toxic for HFFs as host cells and effective against T. gondii. Comparable results were obtained for KP-NPs and blank nanoparticles (BLK-NPs), with no observed toxicity to host cells, confirming that encapsulation did not alter peptide efficacy. The parasiticidal effect of KP alone, as well as KP-NPs at 250 µg/mL and BLK-NPs, was confirmed through tests on free T. gondii tachyzoites. Reduction rates for the number of infected cells ranged from 66% to 90% with respect to control, while the reduction in the number of intracellular tachyzoites ranged from 66% to 80%. Interestingly, KP alone was not effective against intracellular tachyzoite, while KP-NPs maintained an efficacy comparable to the extracellular model, suggesting that particles helped the internalization of the peptide. Conclusions: Encapsulation of KP into hyaluronate/chitosan nanoparticles does not alter its activity and improves its efficacy against the intracellular parasite. Notably, BLK-NPs appeared to exhibit efficacy against the parasite on its own, without the presence of KP.